The Clorox Company $CLX Shares Sold by Teacher Retirement System of Texas

Teacher Retirement System of Texas cut its stake in shares of The Clorox Company (NYSE:CLX) by 8.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 215,234 shares of the company’s stock after selling 19,161 shares during the quarter. Teacher Retirement System of Texas’ holdings in Clorox were worth $25,843,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Spire Wealth Management grew its stake in shares of Clorox by 133.4% during the 1st quarter. Spire Wealth Management now owns 873 shares of the company’s stock worth $129,000 after purchasing an additional 499 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Clorox by 12.4% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 20,799 shares of the company’s stock valued at $3,042,000 after purchasing an additional 2,291 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Clorox by 0.9% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 318,868 shares of the company’s stock valued at $46,953,000 after purchasing an additional 2,886 shares during the period. Verity Asset Management Inc. lifted its stake in shares of Clorox by 135.9% in the first quarter. Verity Asset Management Inc. now owns 7,336 shares of the company’s stock valued at $1,080,000 after purchasing an additional 4,226 shares during the period. Finally, Albion Financial Group UT lifted its stake in shares of Clorox by 8.3% in the first quarter. Albion Financial Group UT now owns 34,774 shares of the company’s stock valued at $5,121,000 after purchasing an additional 2,669 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Trading Down 0.2%

Shares of CLX stock opened at $115.59 on Tuesday. The firm has a 50-day moving average price of $121.10 and a 200 day moving average price of $126.68. The Clorox Company has a twelve month low of $114.95 and a twelve month high of $171.37. The company has a market capitalization of $14.08 billion, a price-to-earnings ratio of 17.73, a PEG ratio of 0.96 and a beta of 0.52. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. During the same quarter in the previous year, the company posted $1.82 EPS. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.3%. Clorox’s payout ratio is presently 76.07%.

Analyst Ratings Changes

Several analysts recently commented on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. Wells Fargo & Company reduced their price objective on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research note on Thursday, September 25th. Bank of America cut their price target on Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft cut their price target on Clorox from $135.00 to $128.00 and set a “hold” rating for the company in a research note on Monday, October 13th. Finally, BNP Paribas Exane cut their price target on Clorox from $118.00 to $110.00 and set an “underperform” rating for the company in a research note on Friday, October 17th. One investment analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and an average target price of $130.20.

Insiders Place Their Bets

In related news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.63% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.